688105.SHG Nanjing Vazyme Biotech Co Ltd

Healthcare Biotechnology Shanghai Stock Exchange
23.90 CNY
Close of Nov 5, 2026
12.89 29.16
Market cap
CNY 12.4B
P/E
-
P/B
3.16x
ROE
0.6%
Dividend yield
0.63%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 688105.SHG undervalued?

Graham number

The Graham number of Nanjing Vazyme Biotech Co Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Nanjing Vazyme Biotech Co Ltd fundamental analysis

No fundamental analysis for Nanjing Vazyme Biotech Co Ltd yet.

Nanjing Vazyme Biotech Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Nanjing Vazyme Biotech Co Ltd

Nanjing Vazyme Biotech Co., Ltd offers technology solutions for life science, biomedicine, and in vitro diagnostics. The company offers nucleic acid extraction reagents, including DNA extraction, RNA extraction, microbiome nucleic acid extraction, sample treatment, and high-throughput automated extraction; molecular biology reagents comprising PCR, cloning/mutagenesis, reverse transcription, real-time PCR (qPCR), one-step RT-PCR/RT-qPCR, nucleic acid electrophoresis, genome …

Full company profile